|
1
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lapidot T, Sirard C, Vormoor J, Murdoch B,
Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA and
Dick JE: A cell initiating human acute myeloid leukaemia after
transplantation into SCID mice. Nature. 367:645–648. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 100:pp.
3983–3988. 2003; View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Singh SK, Clarke ID, Hide T and Dirks PB:
Cancer stem cells in nervous system tumors. Oncogene. 23:7267–7273.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang X, Kruithof-de Julio M, Economides
KD, Walker D, Yu H, Halili MV, Hu YP, Price SM, Abate-Shen C and
Shen MM: A luminal epithelial stem cell is a cell of origin for
prostate cancer. Nature. 461:495–500. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Clarke MF, Dick JE, Dirks PB, Eaves CJ,
Jamieson CH, Jones DL, Visvader J, Weissman IL and Wahl GM: Cancer
stem cells-perspectives on current status and future directions:
AACR workshop on cancer stem cells. Cancer Res. 66:9339–9344. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang YM and Chang JW: Current status and
issues in cancer stem cell study. Cancer Invest. 26:741–755. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vermeulen L, Todaro M, de Sousa Mello F,
Sprick MR, Kemper K, Alea M Perez, Richel DJ, Stassi G and Medema
JP: Single-cell cloning of colon cancer stem cells reveals a
multi-lineage differentiation capacity. Proc Natl Acad Sci USA.
105:pp. 13427–13432. 2008; View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jordan CT: Cancer stem cell biology: From
leukemia to solid tumors. Curr Opin Cell Biol. 16:708–712. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Uchida S, Yokoo S, Yanagi Y, Usui T,
Yokota C, Mimura T, Araie M, Yamagami S and Amano S: Sphere
formation and expression of neural proteins by human corneal stoma
cells in vitro. Invest Ophthalmol Vis Sci. 46:1620–1625. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhu L, Pan QX, Zhang XJ, Xu YM, Chu YJ,
Liu N, Lv P, Zhang GX and Kan QC: Protective effects of matrine on
experimental autoimmune encephalomyelitis via regulation of ProNGF
and NGF signaling. Exp Mol Pathol. 100:337–343. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen JX, Shen HH, Niu M, Guo YM, Liu XQ,
Han YZ, Zhang YM, Zhao YL, Bai BK, Zhou WJ and Xiao XH:
Anti-hepatitis B virus effect of matrine-type alkaloid and
involvement of p38 mitogen-activated protein kinase and tumor
necrosis factor receptor-associated factor 6. Virus Res.
215:104–113. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang JP, Zhang M, Zhou JP, Liu FT, Zhou
B, Xie WF and Guo C: Antifibrotic effects of matrine on in vitro
and in vivo models of liver fibrosis in rats. Acta Pharmacol Sin.
22:183–186. 2001.PubMed/NCBI
|
|
14
|
Liu Y, Xu Y, Ji W, Li X, Sun B, Gao Q and
Su C: Anti-tumor activities of matrine and oxymatrine: Literature
review. Tumor Biol. 35:5111–5119. 2014. View Article : Google Scholar
|
|
15
|
Liao H, Zhao X, Qu J, Zhang J and Cai H:
Matrine suppresses invasion and metastasis of NCI-H1299 cells by
enhancing microRNA-133a expression. Int J Clin Exp Med.
8:10714–10722. 2015.PubMed/NCBI
|
|
16
|
Qian L, Liu Y, Xu Y, Ji W, Wu Q, Liu Y,
Gao Q and Su C: Matrine derivative WM130 inhibits hepatocellular
carcinoma by suppressing EGFR/ERK/MMP-2 and PTEN/AKT signaling
pathways. Cancer Lett. 368:126–134. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang N, Han F, Cui H, Huang J, Wang T,
Zhou Y and Zhou J: Matrine suppresses proliferation and induces
apoptosis in human cholangiocarcinoma cells through suppression of
JAK2/STAT3 signaling. Pharmacol Rep. 67:388–393. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gao HY, Li GY, Lou MM, Li XY, Wei XY and
Wang JH: Hepatoprotective effect of Matrine salvianolic acid B salt
on carbon tetrachloride-induced hepatic fibrosis. J Inflamm.
9:162012. View Article : Google Scholar
|
|
19
|
Xin HB and Liu SF: Effects of matrine on
myocardial contraction and arrhythmia in isolated heart atria.
Zhongguo Yao Li Xue Bao. 8:501–505. 1987.(In Chinese). PubMed/NCBI
|
|
20
|
Wang HQ, Jin JJ and Wang J: Matrine
induces mitochondrial apoptosis in cisplatin-resistant non-small
cell lung cancer cells via suppression of β-catenin/survivin
signaling. Oncol Rep. 33:2561–2566. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang N, Han F, Cui H, Huang J, Wang T,
Zhou Y and Zhou J: Matrine suppresses proliferation and induces
apoptosis in human cholangiocarcinoma cells through suppression of
JAK2/STAT3 signaling. Pharmacol Rep. 67:388–393. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ma Y, Zou F, Xiong J, Wan W, Yin L, Li X,
Bei Z, Yuan L, Meng S, Wang J and Song G: Effect of Matrine on HPAC
cell migration by down-regulating the expression of MT1-MMP via Wnt
signaling. Cancer Cell Int. 15:592015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gilbert CA and Ross AH: Cancer stem cells:
Cell culture, markers and targets for new therapies. J Cell
Biochem. 108:1031–1038. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ke J, Wu X, Wu X, He X, Lian L, Zou Y, He
X, Wang H, Luo Y, Wang L and Lan P: A subpopulation of CD24+ cells
in colon cancer cell lines posse stem cell characteristics.
Neoplasma. 59:282–288. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Smith SC, Oxford G, Wu Z, Nitz MD, Conaway
M, Frierson HF, Hampton G and Theodorescu D: The
metastasis-associated gene CD24 is regulated by Ral GTPase and is a
mediator of cell proliferation and survival in human cancer. Cancer
Res. 66:1917–1922. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang Y, Wei J, Wang H, Xue X, An Y, Tang
D, Yuan Z, Wang F, Wu J, Zhang J and Miao Y: Epithelial mesenchymal
transition correlates with CD24+CD44+ and CD133+ cells in
pancreatic cancer. Oncology Rep. 27:1599–1605. 2012.
|
|
27
|
Inayoshi J, Iehida T, Sugitani S, Tsuboi
Y, Genda T, Honma N and Asakura H: Gross appearance of
hepatocellular careinoma reflects E-cadherin expression and risk of
early recurrence after surgical treatment. J Gastroen Hepatol.
18:673–677. 2003. View Article : Google Scholar
|
|
28
|
Masaki T, Sugiyama M, Matsuoka H, Abe N,
Izumisato Y, Sakamoto A and Atomi Y: Coexpression of matrilysin and
Laminin-5 gamma2 chain may contribute to tumor cell migration in
colorectal carcinomas. Dig Dis Sci. 48:1262–1267. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mohammadizadeh F, Ghasemibasir H, Rajabi
P, Naimi A, Eftekhari A and Mesbah A: Correlation of E-cadherin
expression and routine immunohistochemistry panel in breast
invasive ductal carcinoma. Cancer Biomark. 5:1–18. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kowalski PJ, Rubin MA and Kleer CG:
E-cadherin expression in primary carcinomas of the breast and its
distant metastases. Breast Cancer Res. 5:R217–R222. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yamamoto H, Itoh F, Sakamoto H, Nakajima
Y, Une Y, Hinoda Y and Imai K: Association of reduced cell adhesion
regulator messenger RNA expression with tumor progression in human
hepatocellular carcinoma. Int J Cancer. 74:251–254. 1997.
View Article : Google Scholar : PubMed/NCBI
|
